HR Execs on the Move

Trinity Health New England

www.trinityhealth-ne.org

 
Trinity Health - New England is an integrated health care delivery system comprised of world-class providers and facilities dedicated to the full spectrum of preventive, acute, and post-acute care, all delivered with the triple aim of better health, better care, and lower costs for our patient populations. In New England, our hospitals, walk-in clinics, medical offices, specialized facilities, affiliated institutions, and foundations serve a population of nearly 3 million people. As a dynamic part of Trinity Health, based in Livonia, Michigan, and one of the nation`s largest multi-institutional Catholic health care delivery systems, Trinity Health - New England is uniquely positioned to ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Beverly Coleman
 Executive Director of Human Resources Profile

Similar Companies

Encision Inc.

Encision Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Boulder, CO. To find more information about Encision Inc., please visit www.encision.com

HealthCare Ventures

HealthCare Ventures LLC is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Johnson Regional Medical Center

Johnson Regional Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Clarksville, AR. To find more information about Johnson Regional Medical Center, please visit www.jrmc.com

Lite Source Inc

Lite Source Inc is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.